Abstract
Buprenorphine–naloxone is effective in reducing illicit opioid use, but has a lower overdose risk and fewer adverse effects than methadone.[1][1] Both buprenorphine–naloxone and methadone treatments are associated with reduced all-cause mortality, and both are more effective than abstinence-
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
